NYSE:PHG - New York Stock Exchange, Inc. - US5004723038 - Currency: USD
Mentions: AMZN
February 27, 2025 Accelerating cloud adoption across Europe with Philips HealthSuite Imaging cloud services on Amazon Web Services Amsterdam, The...
February 26, 2025 Philips integrates advanced AI algorithms into its MRI systems, featuring Dual AI-driven engines in SmartSpeed Precise [1] to enable...
February 21, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual...
February 21, 2025 Integrating advanced data analytics into clinical practice to improve patient care Amsterdam, The Netherlands and Cambridge, MA –...
Philips Q4 earnings missed estimates as sales hit €5.04 billion. The company raised its 2023-2025 savings target to €2.5 billion and expects 2025 sales growth of 1%-3%.
Mr David Pyott to retire from Philips’ Supervisory Board after his third consecutive term.Mr Bob White proposed as new member of the Supervisory Board.Ms...
February 19, 2025Full Year and Q4 Group performance highlights Sales of EUR 18.0 billion in 2024, comparable sales growth 1%; EUR 5.0 billion in Q4,...
February 10, 2025 Groundbreaking program that provides technology and training is reducing the impact of stroke, one of the leading causes of death and...
/PRNewswire/ -- Bridgefield Capital, a private investment firm specializing in corporate carve-outs and special situations, announced today that it has entered...
January 9, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the appointment...
December 1, 2024 Philips CT 5300 combines innovative hardware, software, and artificial intelligence to make high-quality screening, diagnostic, and...
December 1, 2024 Philips' intelligent diagnostic and treatment solutions, combined with its advanced capabilities in healthcare informatics, uniquely...
November 26, 2024 Cloud-enabled integrated diagnostics portfolio aims to unify workflows, improve access to critical insights, and drive better outcomes...
November 25, 2024icometrix’ FDA-cleared quantitative brain solution for neurological conditions including Alzheimer’s and multiple sclerosis is seamlessly...